I Can Beat your Sleeve Gastrectomy Without an Incision!

Saturday, September 17, 2022

2:10 PM – 2:30 PM East Coast USA Time

Location: 305

CE: .25

Reference 1: The Lancet, Volume 400, July 28, 2002. Endoscopic sleeve gastroplasty for the treatment of class 1 and 2 obesity: a prospective, mutlicenter, randomized trial.
Reference 2: 0
Reference 3: 0

Member Speaker(s)

Robert G. Snow, DO, FACOS, FASMBS

Bariatric Surgeon
Ultimate Bariatrics

Disclosure(s): Apollo endosurgery: Consultant (Ongoing)

Slides

Disclosure(s):

Robert G. Snow, DO, FACOS, FASMBS: Apollo endosurgery: Consultant (Ongoing)

Learning Objectives:

What is an endoscopic sleeve gastroplasty [ESG]
What isi the data related to weight loss and improvements of co-morbid conditions with the ESG
What is the durability of the ESG
What is the safety profile of ESG
What are the important aspects of the MERIT trial for ESG